San Clemente-based medical device maker AtaCor Medical Inc. said it raised $25 million in a Series B financing round led by an undisclosed corporate partner. It previously raised some $9 million in Oct. 2018.
Participation in the new funding came from current investors Broadview Ventures in Boston and Israel-based aMoon, as well as new buy-ins from Durham, N.C.-based Hatteras, Catalyst Health near Boston, and London-based Longview.
Funds will back pursuit of U.S. and EU regulatory clearance for its extracardiac temporary pacing system—a non-invasive approach that doesn’t require hardware to be placed inside or onto a patient’s heart.
